Core Viewpoint - CarMax, Inc. is facing a class action lawsuit for securities fraud following a significant drop in stock price attributed to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit has been filed against CarMax and certain senior executives, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until January 2, 2026, to request to lead the case in the U.S. District Court for the District of Maryland [3]. Group 2: Financial Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [6]. - The net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [6]. Group 3: Stock Price Impact - Following the financial results announcement on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [7]. - The unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock price drop of over 24% [7]. Group 4: Market Context - CarMax had previously promoted strong demand for its vehicles, which was allegedly inflated by a temporary surge in purchases before U.S. tariffs were imposed [4]. - The company attributed the sales declines to a "pull forward" in demand due to the tariff announcement [6].

Core Viewpoint - Senate Democrats are investigating Fiserv, Inc. and its former CEO Frank Bisignano regarding the company's failure to meet financial forecasts, which has raised concerns about potential misleading information to investors [1][2]. Group 1: Investigation Details - Lawmakers are seeking information on Bisignano's involvement in financial forecasting, his focus on short-term initiatives, and any internal reviews related to financial guidance [2]. - The investigation follows a securities fraud class action lawsuit after Fiserv's stock price dropped 47% on October 29, 2025, due to disappointing Q3 2025 results and reduced guidance [2][5]. - The lawsuit aims to represent investors who acquired Fiserv securities between July 23, 2025, and October 29, 2025, focusing on the accuracy of Fiserv's business statements and growth forecasts [3]. Group 2: Financial Performance - On July 23, 2025, Fiserv revised its 2025 organic revenue guidance to 10% and adjusted its EPS guidance to a low end of $10.15 [4]. - On October 29, 2025, Fiserv reported a sequential decline in Q3 2025 adjusted revenue, slashed organic revenue growth expectations to 3.5%-4%, and reduced EPS outlook to $8.50-$8.60 [5][6]. - The market reacted negatively, causing Fiserv's share price to drop over $59 in intraday trading, resulting in a loss of $32 billion in shareholder value [7]. Group 3: Management Changes - Following the disappointing results, Fiserv announced the departure of its CFO and a shake-up in its board of directors, with new leadership effective January 1, 2026 [5][6]. - The new CEO, Michael Lyons, indicated that the company had conducted a thorough analysis revealing overly optimistic growth assumptions in previous guidance [6].

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into Sanara MedTech Inc. regarding potential violations of federal securities laws, indicating concerns about the company's compliance and the impact on investors [1]. Company Summary - Sanara MedTech Inc. (NASDAQ: SMTI) is currently under scrutiny for possible legal issues that may affect its investors [1]. - The investigation is aimed at assessing the extent of any violations and the implications for shareholders who may have incurred losses [1].

Core Viewpoint - Fortinet, Inc. is facing a securities fraud class action lawsuit due to misleading statements regarding its business operations and financial performance, particularly related to its firewall upgrade cycle and revenue guidance [4][2]. Group 1: Lawsuit Details - The lawsuit is based on allegations that Fortinet made materially false and misleading statements during the class period from November 8, 2024, to August 6, 2025 [4][5]. - The company reported that it was only "approximately 40% to 50% of the way through the 2026 firewall upgrade cycle" by the end of Q2 2025, which contradicted earlier expectations [2][4]. - Following the release of disappointing financial results and guidance, Fortinet's stock price dropped by $21.28, or 22%, closing at $75.30 per share on August 7, 2025 [3][2]. Group 2: Financial Performance - Fortinet's revenue guidance for Q3 2025 was projected between $1.67 billion and $1.73 billion, which was weaker than market expectations [2]. - The lawsuit claims that the refresh cycle for Fortinet's products was not as lucrative as represented, and the company misrepresented the number of firewalls eligible for upgrades [4]. Group 3: Investor Actions - Investors who acquired Fortinet common stock during the class period are urged to participate in the lawsuit, with a deadline set for November 21, 2025, to seek lead plaintiff status [5][4].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until December 23, 2025, to request to be appointed to lead the case [3]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Group 3: Allegations of Fraud - During the relevant period, James Hardie claimed strong performance in its North American fiber cement segment, asserting "inherent strength" and "underlying momentum" in its strategy [5]. - The lawsuit alleges that the reported sales were due to inventory loading by channel partners rather than genuine customer demand, indicating potential fraudulent channel stuffing [5]. Group 4: Stock Performance - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, leading to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [6].

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into Paysafe Limited regarding potential violations of federal securities laws affecting investors [1] Company Summary - Paysafe Limited is listed on the NYSE under the ticker PSFE [1] - The investigation is aimed at assessing the company's compliance with federal securities regulations [1] Investor Impact - The investigation is particularly relevant for investors who have incurred losses on their investments in Paysafe Limited [1]

RADNOR, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 2, 2026. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If ...

Attention Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office is Investigating Claims on Your BehalfNovember 20, 2025 1:55 PM EST | Source: Grabar Law OfficePhiladelphia, Pennsylvania--(Newsfile Corp. - November 20, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.Curr ...

Core Viewpoint - Varonis Systems, Inc. reported disappointing financial results for Q3 2025, leading to a significant decline in stock price and prompting an investigation into potential violations of federal securities laws [2][1]. Financial Performance - Varonis reported a revenue miss against consensus estimates, with a notable 63.9% year-over-year decline in term license subscription revenues [2]. - The company reduced its full-year Annual Recurring Revenue (ARR) guidance due to underperformance in its on-premises subscription business, which was identified as a drag on overall ARR growth [2]. Stock Market Reaction - Following the announcement of poor financial results, Varonis' stock price plummeted by $30.66 per share, or 48.67%, closing at $32.34 per share on October 29, 2025 [2]. Investigation - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of Varonis investors [1].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Zions Bancorporation and its officers or directors [1][2]. Group 1: Company Financials - On October 15, 2025, Zions announced a $50 million charge-off related to a loan from its subsidiary, California Bank & Trust, due to "apparent misrepresentations and contractual defaults by the Borrowers and Obligors and other irregularities" [2]. - Following this announcement, Zions' stock price dropped by $7.10 per share, or 13.14%, closing at $46.93 per share on October 16, 2025 [2]. Group 2: Legal Investigation - Pomerantz LLP, a prominent firm in corporate and securities class litigation, is leading the investigation into Zions Bancorporation [3]. - The firm has a history of recovering significant damages for victims of securities fraud and corporate misconduct [3].